Literature DB >> 21334464

Immunopathogenesis of vitiligo.

Manuel Sandoval-Cruz1, Mario García-Carrasco, Renán Sánchez-Porras, Claudia Mendoza-Pinto, Mario Jiménez-Hernández, Pamela Munguía-Realpozo, Alejandro Ruiz-Argüelles.   

Abstract

Vitiligo is a common depigmenting disorder which may have devastating psychological and social consequences and is characterized by the presence of circumscribed white macules in the skin due to the destruction of melanocytes in the epidermis. Various hypotheses have been proposed to explain the pathomechanisms involved in this disease, and studies have shown the participation of autoimmune processes in the pathogenesis of vitiligo. Cellular and humoral immunities have been implicated in the development of vitiligo and their role continues to be investigated. Peripheral blood and skin biopsies of patients with vitiligo show that T-cells, mononuclear cells, various pro-inflammatory cytokines, and auto-antibodies can damage melanocytes. Further research is required to determine whether autoimmunity is the main mechanism of vitiligo or only a consequence.
Copyright © 2011. Published by Elsevier B.V.

Entities:  

Mesh:

Year:  2011        PMID: 21334464     DOI: 10.1016/j.autrev.2011.02.004

Source DB:  PubMed          Journal:  Autoimmun Rev        ISSN: 1568-9972            Impact factor:   9.754


  41 in total

1.  Oxidative stress-induced overexpression of miR-25: the mechanism underlying the degeneration of melanocytes in vitiligo.

Authors:  Q Shi; W Zhang; S Guo; Z Jian; S Li; K Li; R Ge; W Dai; G Wang; T Gao; C Li
Journal:  Cell Death Differ       Date:  2015-08-28       Impact factor: 15.828

Review 2.  Vitiligo: Focus on Clinical Aspects, Immunopathogenesis, and Therapy.

Authors:  Katia Boniface; Julien Seneschal; Mauro Picardo; Alain Taïeb
Journal:  Clin Rev Allergy Immunol       Date:  2018-02       Impact factor: 8.667

3.  MicroRNA-211 Regulates Oxidative Phosphorylation and Energy Metabolism in Human Vitiligo.

Authors:  Anupama Sahoo; Bongyong Lee; Katia Boniface; Julien Seneschal; Sanjaya K Sahoo; Tatsuya Seki; Chunyan Wang; Soumen Das; Xianlin Han; Michael Steppie; Sudipta Seal; Alain Taieb; Ranjan J Perera
Journal:  J Invest Dermatol       Date:  2017-05-11       Impact factor: 8.551

4.  Type-1 cytokines regulate MMP-9 production and E-cadherin disruption to promote melanocyte loss in vitiligo.

Authors:  Nesrine Boukhedouni; Christina Martins; Anne-Sophie Darrigade; Claire Drullion; Jérôme Rambert; Christine Barrault; Julien Garnier; Clément Jacquemin; Denis Thiolat; Fabienne Lucchese; Franck Morel; Khaled Ezzedine; Alain Taieb; François-Xavier Bernard; Julien Seneschal; Katia Boniface
Journal:  JCI Insight       Date:  2020-06-04

Review 5.  The etiology and molecular genetics of human pigmentation disorders.

Authors:  Laura L Baxter; William J Pavan
Journal:  Wiley Interdiscip Rev Dev Biol       Date:  2012-05-17       Impact factor: 5.814

6.  Chemokines in Vitiligo Pathogenesis: CXCL10 and 12.

Authors:  Khaled Gharib; Hend Gadallah; Ayman Elsayed
Journal:  J Clin Aesthet Dermatol       Date:  2021-09

7.  Inflammatory monocytes are potent antitumor effectors controlled by regulatory CD4+ T cells.

Authors:  Arnaud Pommier; Alexandra Audemard; Aurélie Durand; Renée Lengagne; Arnaud Delpoux; Bruno Martin; Laetitia Douguet; Armelle Le Campion; Masashi Kato; Marie-Françoise Avril; Cédric Auffray; Bruno Lucas; Armelle Prévost-Blondel
Journal:  Proc Natl Acad Sci U S A       Date:  2013-07-22       Impact factor: 11.205

8.  Treatment of vitiligo with a chimeric monoclonal antibody to CD20: a pilot study.

Authors:  A Ruiz-Argüelles; M García-Carrasco; G Jimenez-Brito; S Sánchez-Sosa; B Pérez-Romano; J Garcés-Eisele; C Camacho-Alarcón; V Reyes-Núñez; M Sandoval-Cruz; C Mendoza-Pinto; A López-Colombo
Journal:  Clin Exp Immunol       Date:  2013-11       Impact factor: 4.330

Review 9.  Skin immunity and its dysregulation in atopic dermatitis, hidradenitis suppurativa and vitiligo.

Authors:  Elena Campione; Caterina Lanna; Laura Diluvio; Maria Vittoria Cannizzaro; Sandro Grelli; Marco Galluzzo; Marina Talamonti; Margherita Annicchiarico-Petruzzelli; Mara Mancini; Gerry Melino; Eleonora Candi; Gianfranco Schiavone; Ying Wang; Yufang Shi; Luca Bianchi
Journal:  Cell Cycle       Date:  2020-01-05       Impact factor: 4.534

10.  SFRP5 inhibits melanin synthesis of melanocytes in vitiligo by suppressing the Wnt/β-catenin signaling.

Authors:  Dao-Pei Zou; Yang-Mei Chen; Ling-Zhao Zhang; Xiao-Hui Yuan; Yu-Jie Zhang; Adelina Inggawati; Pham Thi Kieu Nguyet; Tian-Wen Gao; Jin Chen
Journal:  Genes Dis       Date:  2020-06-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.